Revvity Inc (FRA:PKN)
€ 114.9 +9.05 (+8.55%) Market Cap: 13.55 Bil Enterprise Value: 15.56 Bil PE Ratio: 65.12 PB Ratio: 2.12 GF Score: 77/100

Revvity, Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2026 / 12:30 PM GMT
Release Date Price: €105.85 (+1.34%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RVTY.N - Revvity, Inc.
Revvity, Inc. at Morgan Stanley Global Healthcare Conference
Sep 14, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Great. Welcome, everyone. My name is Mike Podold. I lead our US life science tools and diagnostics coverage on the healthcare investment banking side at Morgan Stanley. Pleasure to be joined here by Max Kowiak, the CFO of Revity. So maybe to kick things off, Max, Revity is an organization that's been through a pretty big transformation over the past several years. And so for an investor that's newer to the Revity story. What do you think the simplest way is to kind of understand where the business is today?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, I think as
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot